0001096906-25-001064.txt : 20250903 0001096906-25-001064.hdr.sgml : 20250903 20250627153757 ACCESSION NUMBER: 0001096906-25-001064 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20250627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIBOTICS, INC. CENTRAL INDEX KEY: 0001763329 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 870645794 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 480 22ND STREET CITY: HEYBURN STATE: ID ZIP: 83336 BUSINESS PHONE: 208-677-2020 MAIL ADDRESS: STREET 1: 480 22ND STREET CITY: HEYBURN STATE: ID ZIP: 83336 FORMER COMPANY: FORMER CONFORMED NAME: Mycotopia Therapies, Inc. DATE OF NAME CHANGE: 20210519 FORMER COMPANY: FORMER CONFORMED NAME: 20/20 Global, Inc. DATE OF NAME CHANGE: 20190102 CORRESP 1 filename1.htm

Picture 1 

June 27, 2025

 

US Securities and Exchange Commission

Attn: Joe McCann

Division of Corporation Finance

Office of Life Sciences

Washington, D.C. 20549

 

Re: Aibotics, Inc.  

Offering Statement on Form 1-A Filed May 7, 2025

File No. 024-12597

 

Dear Mr. McCann:

We hereby withdraw our previous request for qualification of the above referenced Offering Statement and replace it with the following. Pursuant to Rule 252(e) promulgated under the Securities Act of 1933, as amended (the "Act"), Aibotics Inc. (the "Company") hereby requests that the Securities and Exchange Commission (the "Commission") issue a qualification order for the above referenced Offering Statement on Form 1A, so that it may be qualified by 4:00 pm., Eastern Time on Tuesday, July 1, 2025, or as soon thereafter as is practicable.

We understand that the Commission has completed its review and has no further comments.

The Company is aware of its responsibilities under the Act, as they relate to this offering of securities. As requested, the Company further acknowledges that:

·Should the Commission or the staff, acting pursuant to delegated authority, qualify the filing, it does not foreclose the Commission from taking any action with respect to the filing; 

·The action of the Commission or the staff, acting pursuant to delegated authority, in qualifying the filing, does not relieve the Company from its responsibility for the adequacy and accuracy of the disclosures in the filing; and 

·The Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. 

The Company acknowledges that the Company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

If you have any questions, please contact our counsel, Jonathan Leinwand (954) 903-7856.

Thank you in advance for your assistance.

Very Truly Yours,

AIBOTICS INC.

By:/s/ Ben Kaplan  

     Ben Kaplan, CEO

Picture 1 

 GRAPHIC 2 tpiacorresp_1.jpg IMAGE begin 644 tpiacorresp_1.jpg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tpiacorresp_2.jpg IMAGE begin 644 tpiacorresp_2.jpg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